Humasis has ranked among the top searched stocks on 5 days within the past month.
As of 2:31 PM on the 10th, Humasis is trading at 14,900 KRW, up 0.68% from the previous day. This marks a 20.16% increase compared to September 4. Humasis is known as an in vitro diagnostic device company.
Over the past 5 days, individual investors have net purchased 25,868 shares, while foreigners and institutions have net purchased 69,338 shares and 34,936 shares respectively.
On September 9, Humasis became a market issue with the news of "COVID-19 antigen test kit export approval, up 16%".
※Source: AI Investment Assistant AI Lassiro
※ This article was generated in real-time by an automatic article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
